Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 3, 2008, Pages 603-608

  Mino, Yasuaki ^a,b   Naito, Takafumi ^a   Matsushita, Tomomi ^a,b   Kagawa, Yoshiyuki ^b   Kawakami, Junichi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Human plasma concentration; Isocratic ion pair HPLC; Mycophenolic acid; Mycophenolic acid acyl glucuronide; Mycophenolic acid phenolic glucuronide

Indexed keywords

AMMONIUM ACETATE; DRUG METABOLITE; GLUCURONIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYCOPHENOLIC ACID ACYLGLUCURONIDE; MYCOPHENOLIC ACID BETA D GLUCURONIDE; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ACIDIFICATION; ARTICLE; BLOOD SAMPLING; CALIBRATION; CLINICAL ARTICLE; DIARRHEA; DRUG DETERMINATION; DRUG METABOLISM; DRUG MONITORING; DRUG STABILITY; DRUG STRUCTURE; ENTERIC COATED TABLET; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNOSUPPRESSIVE TREATMENT; ION PAIR CHROMATOGRAPHY; KIDNEY GRAFT REJECTION; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; GLUCURONIDES; HUMANS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID;

EID: 37749033876     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.11.018     Document Type: Article

References (28)

1. Jeong H., and Kaplan B. Clin. J. Am. Soc. Nephrol. 2 (2007) 184-191
2. Kiberd B.A., Lawen J., Fraser A.D., Keough-Ryan T., and Belitsky P. Am. J. Transplant. 4 (2004) 1079-1083
3. Cransberg K., Marlies Cornelissen E.A., Davin J.C., Van Hoeck K.J., Lilien M.R., Stijnen T., and Nauta J. Pediatr. Transplant. 9 (2005) 104-111
4. Eugui E.M., Almquist S.J., Muller C.D., and Allison A.C. Scand. J. Immunol. 33 (1991) 161-173
5. Shipkova M., Armstrong V.W., Wieland E., Niedmann P.D., Schutz E., Brenner-Weiss G., Voihsel M., Braun F., and Oellerich M. Br. J. Pharmacol. 126 (1999) 1075-1082
6. Nowak I., and Shaw L.M. Ther. Drug Monit. 19 (1997) 358-360
7. Bullingham R.E., Nicholls A.J., and Kamm B.R. Clin. Pharmacokinet. 34 (1998) 429-455
8. Nowak I., and Shaw L.M. Clin. Chem. 41 (1995) 1011-1017
9. Schütz E., Shipkova M., Armstrong V.W., Wieland E., and Oellerich M. Clin. Chem. 45 (1999) 419-422
10. Wieland E., Shipkova M., Schellhaas U., Schutz E., Niedmann P.D., Armstrong V.W., and Oellerich M. Clin. Biochem. 33 (2000) 107-113
11. Shipkova M., Wieland E., Schutz E., Wiese C., Niedmann P.D., Oellerich M., and Armstrong V.W. Transplant. Proc. 33 (2001) 1080-1081
12. Maes B.D., Dalle I., Geboes K., Oellerich M., Armstrong V.W., Evenepoel P., Geypens B., Kuypers D., Shipkova M., Geboes K., and Vanrenterghem Y.F. Transplantation 75 (2003) 665-672
13. Heller T., van Gelder T., Budde K., de Fijter J.W., Kuypers D., Arns W., Schmidt J., Rostaing L., Powis S.H., Claesson K., Macphee I.A., Pohanka E., Engelmayer J., Brandhorst G., Oellerich M., and Armstrong V.W. Am. J. Transplant. 7 (2007) 1822-1831
14. van Gelder T., Le Meur Y., Shaw L.M., Oellerich M., DeNofrio D., Holt C., Holt D.W., Kaplan B., Kuypers D., Meiser B., Toenshoff B., and Mamelok R.D. Ther. Drug Monit. 28 (2006) 145-154
15. Cox V.C., and Ensom M.H. Ther. Drug Monit. 25 (2003) 137-157
16. Hosotsubo H., Takahara S., Imamura R., Kyakuno M., Tanaka T., Yazawa K., Hanafusa T., Matsumiya K., Nonomura N., Okuyama A., and Sugimoto H. Ther. Drug Monit. 23 (2001) 669-674
17. Westley I.S., Ray J.E., and Morris R.G. Ther. Drug Monit. 28 (2006) 632-636
18. Premaud A., Rousseau A., Picard N., and Marquet P. Ther. Drug Monit. 28 (2006) 274-277
19. Schutz E., Shipkova M., Armstrong V.W., Niedmann P.D., Weber L., Tonshoff B., Pethig K., Wahlers T., Braun F., Ringe B., and Oellerich M. Transplant. Proc. 30 (1998) 1185-1187
20. Shipkova M., Schütz E., Armstrong V.W., Niedmann P.D., Oellerich M., and Wieland E. Clin. Chem. 46 (2000) 365-372
21. Patel C.G., and Akhlaghi F. Ther. Drug Monit. 28 (2006) 116-122
22. Khoschsorur G., and Erwa W. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 799 (2004) 355-360
23. Westley I.S., Sallustio B.C., and Morris R.G. Clin. Biochem. 38 (2005) 824-829
24. Brandhorst G., Streit F., Goetze S., Oellerich M., and Armstrong V.W. Clin. Chem. 52 (2006) 1962-1964
25. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Guidance for Industry Bioanalytical Method Validation, May 22, 2001 (Available at: http://www.fda.gov/cder/guidance/4252fnl.htm and accessed on September 12, 2007).
26. Akhlaghi F., Patel C.G., Zuniga X.P., Halilovic J., Preis I.S., and Gohh R.Y. Ther. Drug Monit. 28 (2006) 95-101
27. Picard N., Ratanasavanh D., Prémaud A., Le Meur Y., and Marquet P. Drug Metab. Dispos. 33 (2005) 139-146
28. Saeki M., Saito Y., Jinno H., Tanaka-Kagawa T., Ohno A., Ozawa S., Ueno K., Kamakura S., Kamatani N., Komamura K., Kitakaze M., and Sawada J. Drug Metab. Dispos. 32 (2004) 1048-1054